China Universal Asset Management »

Aeglea Biotherapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $290k 12k 23.28